Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy

被引:39
|
作者
Sengupta, Sadhak [1 ,2 ]
Thaci, Bart [2 ]
Crawford, Andrew C. [3 ]
Sampath, Prakash [1 ,2 ]
机构
[1] Roger Williams Med Ctr, Brain Tumor Lab, Providence, RI 02908 USA
[2] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA
[3] Univ Illinois, Coll Med, Urbana, IL 61801 USA
关键词
CHIMERIC ANTIGEN RECEPTOR; MODIFIED T-CELLS; STEM-CELLS; INTERLEUKIN-13-RECEPTOR-ALPHA-2; CHAIN; HUMAN MONOCYTES; GLIOMA PATIENTS; IN-VIVO; TEMOZOLOMIDE; MULTIFORME; THERAPY;
D O I
10.1155/2014/952128
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Glioblastoma (GBM) is the most lethal primary brain tumor, and despite several refinements in its multimodal management, generally has very poor prognosis. Targeted immunotherapy is an emerging field of research that shows great promise in the treatment of GBM. One of the most extensively studied targets is the interleukin-13 receptor alpha chain variant 2 (IL13R alpha 2). Its selective expression on GBM, discovered almost two decades ago, has been a target for therapy ever since. Immunotherapeutic strategies have been developed targeting IL13R alpha 2, including monoclonal antibodies as well as cell-based strategies such as IL13R alpha 2-pulsed dendritic cells and IL13R alpha 2-targeted chimeric antigen receptor-expressing T cells. Advanced therapeutic development has led to the completion of several clinical trials with promising outcomes. In this review, we will discuss the recent advances in the IL13R alpha 2-targeted immunotherapy and evaluate the most promising strategy for targeted GBM immunotherapy.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines
    Kawakami, K
    Kawakami, M
    Liu, Q
    Puri, RK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01): : 230 - 237
  • [12] Protein- and DNA-Based Active Immunotherapy Targeting Interleukin-13 Receptor Alpha2
    Mintz, Akiva
    Gibo, Denise M.
    MadhanKumar, A. B.
    Cladel, Nancy M.
    Christensen, Neil D.
    Debinski, Waldemar
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (05) : 581 - 589
  • [13] The interleukin-4/interleukin-13 receptor of human synovial fibroblasts:: Overexpression of the nonsignaling interleukin-13 receptor α2
    Feng, NP
    Lugli, SM
    Schnyder, B
    Gauchat, JFM
    Graber, P
    Schlagenhauf, E
    Schnarr, B
    Wiederkehr-Adam, M
    Duschl, A
    Heim, MH
    Lutz, RA
    Moser, R
    LABORATORY INVESTIGATION, 1998, 78 (05) : 591 - 602
  • [14] Interleukin-13 receptor as a unique target for anti-glioblastoma therapy
    Husain, SR
    Joshi, BH
    Puri, RK
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (02) : 168 - 175
  • [15] Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
    Liang, Ruijia
    Wu, Cheng
    Liu, Shiming
    Zhao, Wenyan
    DRUG DELIVERY, 2022, 29 (01) : 1620 - 1630
  • [16] Interleukin-13 receptor α2: glioma's unlucky receptor?
    Gottschalk, Stephen
    CYTOTHERAPY, 2012, 14 (06) : 645 - 646
  • [17] Serum level of interleukin-13 receptor alpha 2 in infants with biliary atresia - is it of value?
    Adawy, Nermin
    El-Araby, Hanaa
    Allam, Alif
    Elshenawy, Soha
    Khedr, Mohammed
    Ibrahim, Yasmine
    Zakaria, Haidy M.
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (02) : 91 - 96
  • [18] EFFICACY OF MUTANT INTERLEUKIN-13 ALPHA-2 RECEPTOR-TARGETED LIPOSOMAL DOXORUBICIN IN THE INTRACRANIAL BRAIN TUMOR MODEL
    Nesterova, Darya
    Madhankumar, Achuthamangalam
    Mrowczynski, Oliver
    Webb, Becky Sue
    Connor, James
    NEURO-ONCOLOGY, 2018, 20 : 282 - 282
  • [19] INTERLEUKIN-13 RECEPTOR A 2 AS A MOLECULAR TARGET FOR MELANOMA
    Nakamura, Kiminori
    Kato, Kazunori
    Sakuragi, Naoya
    Hamada, Hirofumi
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1056 - 1056
  • [20] Interleukin-13 Receptor Alpha2 Is a Novel Therapeutic Target for Human Adrenocortical Carcinoma
    Jain, Meenu
    Zhang, Lisa
    He, Mei
    Patterson, Erin E.
    Nilubol, Naris
    Fojo, Antonio T.
    Joshi, Bharat
    Puri, Raj
    Kebebew, Electron
    CANCER, 2012, 118 (22) : 5698 - 5708